Stay updated on CC-97540 in Severe SLE Clinical Trial

Sign up to get notified when there's something new on the CC-97540 in Severe SLE Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the CC-97540 in Severe SLE Clinical Trial page

  1. Check
    4 days ago
    Change Detected
    Summary
    The study record describes a Phase 1 trial of CC-97540 CAR T cells for severe, refractory autoimmune diseases, with details on eligibility, study locations, treatment, and outcome measures.
    Difference
    85%
    Check dated 2026-11-10T17:22:32.000Z thumbnail image
  2. Check
    11 days ago
    Change Detected
    Summary
    The footer now displays revision v3.8.0 instead of v3.7.2.
    Difference
    0.2%
    Check dated 2026-11-03T17:22:40.000Z thumbnail image
  3. Check
    25 days ago
    Change Detected
    Summary
    A site-wide NIH notice about the transition from “Artificial Intelligence” to “Super Intelligence” appears above the 403 error page, and the footer revision changes from v3.7.1 to v3.7.2.
    Difference
    1%
    Check dated 2026-10-20T19:41:07.000Z thumbnail image
  4. Check
    39 days ago
    Change Detected
    Summary
    The footer revision identifier changed from v3.7.0 to v3.7.1, while the page continues to display a 403 error.
    Difference
    0.2%
    Check dated 2026-10-06T19:50:51.000Z thumbnail image
  5. Check
    53 days ago
    Change Detected
    Summary
    The study record page now displays a 403 Forbidden error instead of the usual study details, blocking access to the record.
    Difference
    20%
    Check dated 2026-09-22T21:48:23.000Z thumbnail image
  6. Check
    60 days ago
    Change Detected
    Summary
    Page revision updated from v3.6.6 to v3.7.0, signaling a new version of the study record. This change appears to be metadata related and does not alter the study content.
    Difference
    0.1%
    Check dated 2026-09-15T21:43:21.000Z thumbnail image

Stay in the know with updates to CC-97540 in Severe SLE Clinical Trial

Enter your email address, and we'll notify you when there's something new on the CC-97540 in Severe SLE Clinical Trial page.